CFTR and cystic fibrosis: Even though clinical and animal experimental data suggest no direct impact on inflammation, modulation and potentiation of the defect CFTR in the recruited PMNs (and macrophages) could add to the observed improved outcome in CF [81], since the membranes of the phagolysosomes contain CFTR [82,83].